Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides

References

• Adamson D C, Wildemann B, Sasak M I, Glass J D, McArthur J C, Christov V I, Dawson T M, Dawson V L. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV‐1 gp41. Science 1996; 274: 1917–1921
   PubMed Web of Science ®Google Scholar
• Aisen P S. Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontol 1997; 43: 143–149
   PubMed Web of Science ®Google Scholar
• Akatsu H, Yamada T, Okada N, Yamamoto T, Yamashina M, Okad H A. Unique expression of HRF (CD59) in human nervous tissue. Microbiol Immunol 1997; 41: 321–329
   Google Scholar
• Aries S P, Schaaf B, Hansen F, Weyrich K, Kurowski V, Dennin R, Dalhoff K. Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus‐1 infected individuals. Eur Resp J 1997; 10: 1736–1741
   Google Scholar
• Cadman E D, Puttfarcken P S. β‐amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro. Expt Neuronal 1997; 146: 388–394
   Google Scholar
• Chong Y H. Effect of a carboxy‐terminal fragment of the Alzheimer amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells. Life Sci 1997; 23: 2323–2333
   Google Scholar
• Chomczinsky P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 1987; 162: 156–159
   Google Scholar
• Corasaniti M T, Melino G, Navarra M, Garaci E, Finazzi‐Agro A, Nistico G. Death of cultured neuroblastoma cells induced by HIV‐1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cycloxygenase. Neurodegen 1995; 4: 315–321
   Google Scholar
• Denner J, Norley S, Kurth R. The immunosupp ressive peptide of HIV‐1: functional domains and immune response in AIDS patients. AIDS 1994; 8: 1063–1072
   PubMed Web of Science ®Google Scholar
• Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic cell lines. Nature 1984; 307: 273–276
   PubMed Web of Science ®Google Scholar
• Gasque P, Morgan B P. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunol 1996a; 89: 338–347
   Google Scholar
• Gasque P, Thomas A, Fontaine M, Morgan B P. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J Neuroimmunol 1996b; 66: 29–40
   PubMed Web of Science ®Google Scholar
• Glass J D, Johnson R T. Human immunodeficiency virus and the brain. Annu Rev Neurosci 1996; 19: 1–26
   PubMed Web of Science ®Google Scholar
• Haraguchi S, Good R A, Day N K. Immunosupp ressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 1995; 16: 595–603
   PubMedGoogle Scholar
• Herzenberg L A, De Rosa S C, Dubs J G, Roederer M, Anderson M T, Ela S W, Herzenberg L A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 1997; 94: 1967–1972
   PubMed Web of Science ®Google Scholar
• Holguin M H, Martin C B, Eggett T, Parker C J. Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter. J Immunol 1996; 157: 1659–1668
   Google Scholar
• Itescu S. Rheumatic aspects of acquired immunodeficiency syndrome. Cur Opin Rheumatol 1996; 8: 346–353
   Google Scholar
• Jones J, Morgan B P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunol 1995; 86: 651–660
   Google Scholar
• Kalebic T, Masiero L, Onisto M, Garbisa S. HIV‐1 modulates the expression of gelatinase A and B in monocyic cells. Biochem Biophy Res Comm 1994; 205: 1243–1249
   PubMedGoogle Scholar
• Koka P, He K, Zack J A, Kitchen S, Peacock W, Fried I, Tran T, Yashar S S, Merrill J E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995; 182: 941–951
   PubMed Web of Science ®Google Scholar
• Marchbank K J, Morgan B P, Van Den Berg C W. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross‐linking antibody and non‐lethal complement attack. Immunol 1995; 85: 146–152
   Google Scholar
• Marschang P, Kruger U, Ochsenbauer C, Gurtler L, Hittmair A, Bosch V, Patsch J R, Dierich M P. Complement activation by HIV‐1 infected cells: the role of transmembrane glycoprotein gp41. J. Acq. Immun. Deficiency Syndrome. J Acquired Immune Defic Syndr Hum Retrovirol 1997; 14: 102–109
   PubMedGoogle Scholar
• Masliah E, Achim C L, Ge N, Eeteresa R D, Terry R D, Wiley C A. Spectrum of human immunodeficiency virus‐associated neocortical damage. Ann Neurol 1992; 32: 321–329
   PubMed Web of Science ®Google Scholar
• McGeer P I, McGeer E G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995; 21: 195–218
   PubMed Web of Science ®Google Scholar
• Meri S, Morgan B P, Davies A, Danials R H, Olavesen M G, Waldmaann H, Lachmaann P J. Human protein (CD59), an 18,000–20,000 MW complement lysis restriction factor, inhibits C5b‐8 catalysed insertion of C9 into lipid bilayers. Immunol 1990; 71: 1–9
   PubMed Web of Science ®Google Scholar
• Mizuguchi M, Ikeda K, Namba Y, Kim S U. Alzheimer's disease β‐amyloid precursor protein in rat neural cells in culture. Gerontol 1992; 38: 15–23
   Google Scholar
• Montefiori D C, Cornell R J, Zhou Z Y, Zhou Z T, Hirsch V M, Johnson P R. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and siminan viruses and possible targets for vaccine protection. Virol 1994; 205: 82–92
   PubMed Web of Science ®Google Scholar
• Morgan B P. Clinical complementology: Recent progress and future trends. Eur J Clinic Invest 1994; 24: 219–228
   PubMedGoogle Scholar
• Morgan B P, Gasque P, Singhrao S, Piddlesden S J. The role of complement in disorders of the nervous system. Immunopharmacol 1997; 38: 43–50
   PubMedGoogle Scholar
• Nokia M A, Hassan M I, Morgan J A, Loesch K A, Pollard K B. Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)‐induced cellularhyporesponsiveness. Proc Soc Exp Biol Med 1994; 207: 284–291
   Google Scholar
• Nottet H S, Jett M, Flanagan C R, Zhai Q H, Persidky Y, Rizzimo A, Berton E W, Cents P, Baldwin T, Schwartz J, Labenz C J, Gendehnan H E. A regulatory role for astrocytes in HIV‐1 encephalitis: An overexpression of eicosanoids, platelet‐activating factor, and tumor necrosis factor, by activated HIV‐1‐infected monocytes is attenuated by primary human astrocytes. J Immunol 1995; 154: 3567–3581
   PubMed Web of Science ®Google Scholar
• Ogino Y, Costa T. The epithelial phenotype of human neuroblastoma cells express bradykinin. J. Neurochem J Neurochem 1992; 58: 46–56
   Google Scholar
• Poute P, Ng S ‐Y, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of act in mRNAs: DNA sequence of a human beta‐actin cDNA. Nucleic Acids Res 1984; 12: 1687–1696
   Google Scholar
• Ratner L, Haseltino W, Partarca R, Livak K J, Statcich B, Josephs S F, Doran E R, Rafaski J A, Whitehorn E A, Baumeister K, Ivanoff L, Peytteway S R J R, Pearson J A, Lautenberger M L, Papas T S, Ghrayeb J, Chang N T, Gallo R, Wong‐Staal C F. Complete nucleotide sequence) of the AIDS virus, HTLV.‐III. Nature 1985; 313: 277–284
   PubMed Web of Science ®Google Scholar
• Rogers C A, Gasque P, Piddlesden S J, Okada N, Holers V M, Morgan B P. Expression and function of membrane regulators of complement on rat astrocytes in culture. Immunol 1996; 88: 153–161
   PubMed Web of Science ®Google Scholar
• Rogers J, Cooper N, Webster S, Schultz J, McGeer P, Styren S D, Civin W H, Brachova L, Bradt B, Ward P, Lieberburg I. Complement activation by β‐amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 1992; 89: 10016–10020
   PubMed Web of Science ®Google Scholar
• Ruegg C L, Strand M A. Synthetic peptide with sequence identity to the transmembrane protein Gp41 of HIV‐1 inhibits distinct lymphocytes activation pathways dependent on protein kinase C and intracellular calcium influx. Cell Immunol 1991; 137: 1–13
   Google Scholar
• Saifuddin M, Hedayati T, Atkinson J P, Holguin M H, Parker C J, Spear C T. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol‐anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement‐mediated destruction. J Gen Virol 1997; 78: 1907–1911
   PubMed Web of Science ®Google Scholar
• Sawada R, Ohashi K, Anaguchi H, Okazaki H, Hattori M, Minao N, Naruto M. Isolation and expression of the full‐length cDNA encoding CD59 antigen of human lymphocytes. DNA Cell Biol 1992; 9: 213–220
   Google Scholar
• Schmitz J, Zimmer J P, Kluxen B, Aries S, Bogel M, Gigli I, Schmitz H. Antibody‐dependent complement mediated cytotoxicity in sera from patients with HIV‐1 infection is controlled by CD55 and CD59. J Clin Invest 1995; 96: 1520–1526
   PubMed Web of Science ®Google Scholar
• Shen Y, Sullivan T, Lee C ‐M, Meri S, Shiosaki K, Lin C W. Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β‐amyloid peptide. Brain Res 1998; 796: 187–197
   PubMedGoogle Scholar
• Spiller O B, Moretto C, Ki S U, Morgan B P, Devine D V. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression. J Neuroimmunol 1996; 71: 97–106
   Google Scholar
• Stoiber H, Clivio A, Dierich M P. Role of complement in HIV infection. Anna Rev Immunol 1997; 15: 649–674
   PubMed Web of Science ®Google Scholar
• Thielens N M, Bally I M, Ebenbichler C F, Dierich M P. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV‐1. J Immunol 1993; 151: 6583–6592
   Google Scholar
• Toggas S M, Masliah E, Rockenstein E M, Mucke L. Central nervous system damage produced by expression of the HIV‐1 coat protein gp120 in transgenic mice. Nature 1994; 367: 188–193
   PubMed Web of Science ®Google Scholar
• Tsuji S, Kaji K, Nagasawa S. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J Biochem 1994; 116: 794–800
   PubMed Web of Science ®Google Scholar
• Weiss L, Okada N, Haeffner Cavaillon N, Hattori T, Faucher C, Kazatchkine M D, Okada H. Decreased expression of the membrane inhibitor of complement‐mediated cytolysis CD59 on T‐lympliocytes of HIV‐infected patients. AIDS 1992; 6: 379–385
   Google Scholar
• Yeung M C, Pulliam L, Lau A S. The HIV envelope protein gp120 is toxic to human brain‐cell cultures through the induction of interlcukin‐6 and tumor necrosis factor. AIDS 1995; 9: 137–143
   PubMed Web of Science ®Google Scholar